Scientific Sessions 2024  /  Emerging Therapies for Treatment of Hypertension and Chronic Kidney Disease  /  Endothelin antagonists for management of resistant hypertension?
Logo

American Heart Association

  2
  0

Final ID:

Endothelin antagonists for management of resistant hypertension?

  • Piskorz, Daniel  ( Instituto de Cardiología del Sanatorio Británico , Rosario , Argentina )
  • Penaherrera, Ernesto  ( Hospital Luis Vernaza , Guayaquil , Ecuador )
    • Author Disclosures:
    Daniel Piskorz: DO NOT have relevant financial relationships | Ernesto Penaherrera: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Emerging Therapies for Treatment of Hypertension and Chronic Kidney Disease

Friday, 11/15/2024 , 04:00PM - 05:15PM

Cardiovascular Seminar

More abstracts on this topic:
Non-steroidal MRAs- where do they fit in our HTN treatment toolbox?

Vongpatanasin Wanpen, Kirabo Annet

Aldosterone synthase inhibitors: new kids on the block

Turcu Adina, Vaidya Anand

More abstracts from these authors:
Priorities for Improving Cardiometabolic Health in the Americas

Piskorz Daniel

You have to be authorized to contact abstract author. Please, Login
Not Available